Improved left ventricular function after chronic left ventricular unloading

Annals of Thoracic Surgery

Volumn 62, Issue 3, 1996, Pages 675-682

  Frazier, O H ^a,b   Benedict, Claude R ^a   Radovancevic, Branislav ^a   Bick, Roger J ^a   Capek, Pavel ^a   Springer, William E ^a   Macris, Michael P ^a   Delgado, Reynolds ^a   Buja, L Maximilian ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CLINICAL ARTICLE; DEVICE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE EJECTION; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0030246896     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00437-7     Document Type: Article

References (29)

1. 1. Levine S. Clinical heart disease, 3rd ed. Philadelphia: Saunders, 1945:269.
2. 2. McDonald CD, Burch GE, Walsh JJ. Alcoholic cardiomyopathy with prolonged bed rest. Ann Int Med 1971;74:681-91.
3. 3. Norman JC. Mechanical ventricular assistance: a review, Artif Organs 1981;5:103-17.
4. 4. Norman JC, Brook MI, Cooley DA, et al. Total support of the circulation of a patient with post-cardiotomy artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1978;1:1125-7.
5. 5. Norman JC, Duncan JM, Frazier OH, et al. Intracorporeal (abdominal) left ventricular assist devices or partial artificial hearts: a five-year clinical experience. Ann Surg 1981;116: 1441-5.
6. 6. Frazier OH. Long-term ventricular support with the Heart-Mate in patients undergoing bridge-to-transplant operation. Cardiac Surg State Art Rev 1993;7:353-62.
7. 7. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-38.
8. 8. Rouser G, Siakotos AN, Fleischer S. Quantitative analysis of phospholipids by thin layer chromatography and the phosphorus analysis of spots. Lipids 1966;1:85-6.
9. 9. Hussain MN, Benedict CR. Radioenzymatic microassay for simultaneous estimation of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues. Clin Chem 1985; 31:1861-4.
10. 10. Harasaki H, Zheng Z, Morimoto T, et al. Morphometric studies of the failing heart. Trans Am Soc Artif Intern Organs 1985;31:73-8.
11. 11. Kinoshita M, Takano H, Taenaka Y, et al. Cardiac atrophy during LVAS pumping. ASAIO Trans 1988;34:208-12.
12. 12. Migliore JJ, Hughes DA, Edmonds CH, Fuqua JM, Daly BDT, Norman JC. An abdominal left ventricular assist device: resumption of left ventricular pressure generation following profound acute and chronic unloading in the dog and calf. 27th Annual Conference on Engineering in Medicine and Biology, Philadelphia, PA, Oct 6-10, 1974.
13. 13. Scheinin SA, Capek P, Radovancevic B, Duncan JM, McAllister HA, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 1992;38:M271-4.
14. 14. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 1994;89:2908-14.
15. 15. Ito Y, Suko J, Chidsey CA. Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts. J Mol Cell Cardiol 1974;6:237-47.
16. 16. Katz AM, Messineo F, Nash-Adler P. Effects of amphiphilic substances on sarcoplasmic reticulum function. In: Entman ML, Van Winkle WB, eds. Sarcoplasmic reticulum in muscle physiology, Vol II. Boca Raton, FL: CRC Press, 1986:123-39.
17. 17. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-43.
18. 18. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-69.
19. 19. Wynne J, Braunwald E. The cardiomyopathies and myocarditides: toxic, chemical, and physical damage to the heart. In: Braunwald E, ed. Heart disease: A textbook of cardiovascular medicine. Philadelphia: Saunders, 1992:1394-450.
20. 20. Bender JR. Idiopathic dilated cardiomyopathy: an immunologic, genetic, or infectious disease, or all of the above? 1991; 83:704-6.
21. 21. McAllister HA, Buja LM, Ferrans VJ. Anatomic abnormalities. In: Willerson JT, Cohn JN, eds. Cardiovascular medicine. New York: Churchill Livingstone, 1995:832-4.
22. 22. Burch GE. On resting the human heart. Am Heart J 1966;71: 422.
23. 23. Bauer LHB, Schipperheyn JB, van der Laarse A, et al. Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure. Br Heart J 1991;65:137-42.
24. 24. Hall S, Cigarroa C, Marcouz L, et al. Regression of hypertrophy and alteration in left ventricular geometry in patients with congestive heart failure treated with beta-adrenergic blockade. Circulation 1994;90(Suppl 1):543.
25. 25. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilatation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20.
26. 26. McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609-13.
27. 27. James KB, McCarthy PM, Vargo R, Hobbs RE, Bravo E. The effect of the implantable left ventricular assist device on neurohormones in heart failure. Circulation 1994;90(Suppl 1)-47.
28. 28. Mandarino WA, Gorcsan J, Gasior TA, Pham S, Griffith BP, Kormos RL. Estimation of left ventricular function in patients with a left ventricular assist device. ASAIO J 1995;41: M544-7.
29. 29. Frazier OH, Radovancevic B, Abou-Awdi NL, et al. Ventricular remodelling after prolonged ventricular unloading "heart rest": experience with the HeartMate left ventricular assist device. J Heart Lung Transplant 1994;13:S51.